FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3102628359> ?p ?o ?g. }

• W3102628359 endingPage "1139" @default.
• W3102628359 startingPage "1131" @default.
• W3102628359 abstract "Pregnant women with inflammatory bowel disease (IBD) may require biologic or thiopurine therapy to control disease activity. Lack of safety data has led to therapy discontinuation during pregnancy, with health repercussions to mother and child.Between 2007 and 2019, pregnant women with IBD were enrolled in a prospective, observational, multicenter study across the United States. The primary analysis was a comparison of 5 outcomes (congenital malformations, spontaneous abortions, preterm birth, low birth weight, and infant infections) among pregnancies exposed vs unexposed in utero to biologics, thiopurines, or a combination. Bivariate analyses followed by logistic regression models adjusted for relevant confounders were used to determine the independent effects of specific drug classes on outcomes of interest.Among 1490 completed pregnancies, there were 1431 live births. One-year infant outcomes were available in 1010. Exposure was to thiopurines (n = 242), biologics (n = 642), or both (n = 227) vs unexposed (n = 379). Drug exposure did not increase the rate of congenital malformations, spontaneous abortions, preterm birth, low birth weight, and infections during the first year of life. Higher disease activity was associated with risk of spontaneous abortion (hazard ratio, 3.41; 95% confidence interval, 1.51-7.69) and preterm birth with increased infant infection (odds ratio, 1.73; 95% confidence interval, 1.19-2.51).Biologic, thiopurine, or combination therapy exposure during pregnancy was not associated with increased adverse maternal or fetal outcomes at birth or in the first year of life. Therapy with these agents can be continued throughout pregnancy in women with IBD to maintain disease control and reduce pregnancy-related adverse events. ClinicalTrials.gov, Number: NCT00904878." @default.
• W3102628359 created "2020-11-23" @default.
• W3102628359 creator A5007438752 @default.
• W3102628359 creator A5017140014 @default.
• W3102628359 creator A5019008409 @default.
• W3102628359 creator A5019801327 @default.
• W3102628359 creator A5023182644 @default.
• W3102628359 creator A5032150391 @default.
• W3102628359 creator A5042813574 @default.
• W3102628359 creator A5071230912 @default.
• W3102628359 creator A5083006820 @default.
• W3102628359 date "2021-03-01" @default.
• W3102628359 modified "2023-10-06" @default.
• W3102628359 title "Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease" @default.
• W3102628359 cites W1622670858 @default.
• W3102628359 cites W1963498335 @default.
• W3102628359 cites W1980639584 @default.
• W3102628359 cites W1983770110 @default.
• W3102628359 cites W1984455842 @default.
• W3102628359 cites W1991865906 @default.
• W3102628359 cites W2006713077 @default.
• W3102628359 cites W2022661087 @default.
• W3102628359 cites W2037551631 @default.
• W3102628359 cites W2042927462 @default.
• W3102628359 cites W2059843231 @default.
• W3102628359 cites W2072010523 @default.
• W3102628359 cites W2072196543 @default.
• W3102628359 cites W2092134373 @default.
• W3102628359 cites W2108332624 @default.
• W3102628359 cites W2156275748 @default.
• W3102628359 cites W2185850265 @default.
• W3102628359 cites W2252797808 @default.
• W3102628359 cites W2316715874 @default.
• W3102628359 cites W2597714858 @default.
• W3102628359 cites W2811211257 @default.
• W3102628359 cites W2910459213 @default.
• W3102628359 cites W3004377487 @default.
• W3102628359 doi "https://doi.org/10.1053/j.gastro.2020.11.038" @default.
• W3102628359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7956164" @default.
• W3102628359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33227283" @default.
• W3102628359 hasPublicationYear "2021" @default.
• W3102628359 type Work @default.
• W3102628359 sameAs 3102628359 @default.
• W3102628359 citedByCount "116" @default.
• W3102628359 countsByYear W31026283592021 @default.
• W3102628359 countsByYear W31026283592022 @default.
• W3102628359 countsByYear W31026283592023 @default.
• W3102628359 crossrefType "journal-article" @default.
• W3102628359 hasAuthorship W3102628359A5007438752 @default.
• W3102628359 hasAuthorship W3102628359A5017140014 @default.
• W3102628359 hasAuthorship W3102628359A5019008409 @default.
• W3102628359 hasAuthorship W3102628359A5019801327 @default.
• W3102628359 hasAuthorship W3102628359A5023182644 @default.
• W3102628359 hasAuthorship W3102628359A5032150391 @default.
• W3102628359 hasAuthorship W3102628359A5042813574 @default.
• W3102628359 hasAuthorship W3102628359A5071230912 @default.
• W3102628359 hasAuthorship W3102628359A5083006820 @default.
• W3102628359 hasBestOaLocation W31026283592 @default.
• W3102628359 hasConcept C126322002 @default.
• W3102628359 hasConcept C131872663 @default.
• W3102628359 hasConcept C156957248 @default.
• W3102628359 hasConcept C187212893 @default.
• W3102628359 hasConcept C207103383 @default.
• W3102628359 hasConcept C2776344615 @default.
• W3102628359 hasConcept C2778260677 @default.
• W3102628359 hasConcept C2778279030 @default.
• W3102628359 hasConcept C2778376644 @default.
• W3102628359 hasConcept C2778642596 @default.
• W3102628359 hasConcept C2778715236 @default.
• W3102628359 hasConcept C2779083892 @default.
• W3102628359 hasConcept C2779134260 @default.
• W3102628359 hasConcept C2779234561 @default.
• W3102628359 hasConcept C2779280984 @default.
• W3102628359 hasConcept C44249647 @default.
• W3102628359 hasConcept C54355233 @default.
• W3102628359 hasConcept C70917649 @default.
• W3102628359 hasConcept C71924100 @default.
• W3102628359 hasConcept C86803240 @default.
• W3102628359 hasConceptScore W3102628359C126322002 @default.
• W3102628359 hasConceptScore W3102628359C131872663 @default.
• W3102628359 hasConceptScore W3102628359C156957248 @default.
• W3102628359 hasConceptScore W3102628359C187212893 @default.
• W3102628359 hasConceptScore W3102628359C207103383 @default.
• W3102628359 hasConceptScore W3102628359C2776344615 @default.
• W3102628359 hasConceptScore W3102628359C2778260677 @default.
• W3102628359 hasConceptScore W3102628359C2778279030 @default.
• W3102628359 hasConceptScore W3102628359C2778376644 @default.
• W3102628359 hasConceptScore W3102628359C2778642596 @default.
• W3102628359 hasConceptScore W3102628359C2778715236 @default.
• W3102628359 hasConceptScore W3102628359C2779083892 @default.
• W3102628359 hasConceptScore W3102628359C2779134260 @default.
• W3102628359 hasConceptScore W3102628359C2779234561 @default.
• W3102628359 hasConceptScore W3102628359C2779280984 @default.
• W3102628359 hasConceptScore W3102628359C44249647 @default.
• W3102628359 hasConceptScore W3102628359C54355233 @default.
• W3102628359 hasConceptScore W3102628359C70917649 @default.
• W3102628359 hasConceptScore W3102628359C71924100 @default.
• W3102628359 hasConceptScore W3102628359C86803240 @default.

• next